{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:57:03Z","timestamp":1784289423467,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.compbiolchem.2024.108311","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T16:29:39Z","timestamp":1733588979000},"page":"108311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Exploring immune gene expression and potential regulatory mechanisms in anaplastic thyroid carcinoma using a combination of single-cell and bulk RNA sequencing data"],"prefix":"10.1016","volume":"115","author":[{"given":"Kehui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiabin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2024.108311_bib1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11095-022-03444-2","article-title":"Selective COX-2 inhibitor etoricoxib\u2019s liposomal formulation attenuates M2 polarization of TAMs and enhances its anti-metastatic potential","volume":"40","author":"Akif","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib2","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1210\/jc.2015-4227","article-title":"Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer","volume":"101","author":"Bastman","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib3","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.4049\/jimmunol.176.8.4843","article-title":"SUMOylation interferes with CCAAT\/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells","volume":"176","author":"Berberich-Siebelt","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/thy.2016.0254","article-title":"Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases","volume":"27","author":"Bonhomme","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib7","first-page":"189","article-title":"Natural killer activity in thyroid cancer patients","volume":"20","author":"Boros","year":"1987","journal-title":"Haematol. (Budap)"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib8","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/onc.2010.169","article-title":"Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas","volume":"29","author":"Braun","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cncr.31059","article-title":"The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?","volume":"124","author":"Burtness","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib10","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.19.02727","article-title":"PD-1 blockade in anaplastic thyroid carcinoma","volume":"38","author":"Capdevila","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12110","article-title":"Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation","volume":"12","author":"Chen","year":"2008","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib12","doi-asserted-by":"crossref","first-page":"30356","DOI":"10.1074\/jbc.272.48.30356","article-title":"Antioxidant-induced nuclear translocation of CCAAT\/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299","volume":"272","author":"Chinery","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1210\/jc.2016-3756","article-title":"Expression of PD-1 and PD-L1 in anaplastic thyroid cancer patients treated with multimodal therapy: results from a retrospective study","volume":"102","author":"Chintakuntlawar","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cells7090133","article-title":"NFKB1 and cancer: friend or foe?","volume":"7","author":"Concetti","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib15","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3390\/curroncol29040217","article-title":"P144 a transforming growth factor beta inhibitor peptide, generates antifibrogenic effects in a radiotherapy induced fibrosis model","volume":"29","author":"Cruz-Morande","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.3390\/ijms21072268","article-title":"Thymosin \u03b24 identified by transcriptomic analysis from HF anagen to telogen promotes proliferation of SHF-DPCs in albas cashmere Goat","volume":"21","author":"Dai","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib17","first-page":"10","article-title":"Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced m2-polarization of macrophages","volume":"60","author":"Dubey","year":"2014","journal-title":"Cell Mol. Biol. (Noisy-Le. -Gd. )"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib19","doi-asserted-by":"crossref","first-page":"20474","DOI":"10.1074\/jbc.M602859200","article-title":"The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid","volume":"281","author":"Eisinger","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cncr.31063","article-title":"Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma","volume":"124","author":"Gleber-Netto","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib21","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1074\/jbc.M312398200","article-title":"Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells","volume":"279","author":"Grundstr\u00f6m","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-022-02316-2","article-title":"OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of anaplastic thyroid cancer","volume":"41","author":"Gugnoni","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13045-021-01184-1","article-title":"The roles of GTPase-activating proteins in regulated cell death and tumor immunity","volume":"14","author":"He","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib24","doi-asserted-by":"crossref","unstructured":"Ikezoe, T., Yang, Y., Saitoh, T., Heber, D., McKENNA, R., Taguchi, H., Koeffler, H.P., 2006. PC-SPES down-regulates COX-2 via inhibition of NF-\u03baB and C\/EBP\u00df in non-small cell lung cancer cells. INTERNATIONAL JOURNAL OF ONCOLOGY.","DOI":"10.3892\/ijo.29.2.453"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib25","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3390\/nu14081564","article-title":"Ginsenoside Rh4 suppresses metastasis of gastric cancer via SIX1-dependent TGF-\u03b2\/Smad2\/3 signaling pathway","volume":"14","author":"Jiang","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/thy.2011.0380","article-title":"Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-\u03baB activation in anaplastic thyroid carcinoma cells","volume":"22","author":"Kim","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1369\/00221554221138370","article-title":"Aberrant expression of thymosin beta-4 correlates with advanced disease and BRAF V600E mutation in thyroid cancer","volume":"70","author":"Kuo","year":"2022","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41419-018-0601-2","article-title":"CD47-ligation induced cell death in T-acute lymphoblastic leukemia","volume":"9","author":"Leclair","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib30","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1089\/thy.2016.0147","article-title":"Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma","volume":"26","author":"Lee","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4049\/jimmunol.176.1.603","article-title":"NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription","volume":"176","author":"Lee","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/bj20011798","article-title":"Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2","volume":"365","author":"Levin","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13046-019-1198-8","article-title":"Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism","volume":"38","author":"Mazzoni","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib34","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1210\/en.2008-0279","article-title":"Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cells","volume":"149","author":"Meng","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acsmedchemlett.0c00679","article-title":"Discovery of selective transforming growth factor \u03b2 Type II receptor inhibitors as antifibrosis agents","volume":"12","author":"Miwa","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib36","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1002\/jcp.28504","article-title":"NF-\u03baB targeting for overcoming tumor resistance and normal tissues toxicity","volume":"234","author":"Mortezaee","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib37","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1242\/jcs.02579","article-title":"The NF-kappaB pathway","volume":"118","author":"Moynagh","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.18632\/oncotarget.1569","article-title":"Perspectives of TGF-\u03b2 inhibition in pancreatic and hepatocellular carcinomas","volume":"5","author":"Neuzillet","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib39","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm0904-887","article-title":"Cancer immunotherapy: breaking the barriers to harvest the crop","volume":"10","author":"Pardoll","year":"2004","journal-title":"Nat. Med"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib41","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/sj.onc.1206478","article-title":"Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways","volume":"22","author":"Park","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib42","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1038\/s41467-019-12517-7","article-title":"De novo compartment deconvolution and weight estimation of tumor samples using DECODER","volume":"10","author":"Peng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib43","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib44","article-title":"Anaplastic thyroid cancer: an update","volume":"37","author":"Rao","year":"2023","journal-title":"Best. Pr. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/thy.2016.0395","article-title":"Patterns of treatment failure in anaplastic thyroid carcinoma","volume":"27","author":"Rao","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib46","first-page":"465","article-title":"Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation","volume":"27","author":"Rho","year":"2005","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-018-0903-0","article-title":"Therapeutic advances in anaplastic thyroid cancer: a current perspective","volume":"17","author":"Saini","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clon.2010.03.013","article-title":"Anaplastic thyroid carcinoma: pathogenesis and emerging therapies","volume":"22","author":"Smallridge","year":"2010","journal-title":"Clin. Oncol. (R. Coll. Radio.)"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/joim.13505","article-title":"Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials","volume":"292","author":"Stiller","year":"2022","journal-title":"J. Intern Med"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2017.73.6785","article-title":"Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600-mutant anaplastic thyroid cancer","volume":"36","author":"Subbiah","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib53","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/mco.2013.170","article-title":"Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer","volume":"1","author":"Suzuki","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1742951","article-title":"CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers","volume":"2018","author":"Tuccilli","year":"2018","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib55","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.4049\/jimmunol.179.8.5378","article-title":"The C\/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing","volume":"179","author":"Uematsu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib56","article-title":"Single-cell transcriptome analysis reveals inter-tumor heterogeneity in bilateral papillary thyroid carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib57","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-14-0291","article-title":"Human anaplastic thyroid carcinoma cells are sensitive to NK cell\u2013mediated lysis via ULBP2\/5\/6 and chemoattract NK cells","volume":"20","author":"Wennerberg","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib58","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2006-0492","article-title":"Clinicopathological significance of major histocompatibility complex class I-related chain A and b expression in thyroid cancer","volume":"91","author":"Xu","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib59","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/thy.2020.0086","article-title":"Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases","volume":"30","author":"Xu","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.compbiolchem.2024.108311_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113826","article-title":"The genomic and evolutionary landscapes of anaplastic thyroid carcinoma","volume":"43","author":"Zeng","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib61","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1074\/jbc.M117.809657","article-title":"Prodomain-growth factor swapping in the structure of pro-TGF-\u03b21","volume":"293","author":"Zhao","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib62","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.178.4.2155","article-title":"Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance","volume":"178","author":"Zhou","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib63","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fimmu.2017.00816","article-title":"Natural killer cell (NK-92MI)-based therapy for pulmonary metastasis of anaplastic thyroid cancer in a nude mouse model","volume":"8","author":"Zhu","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.compbiolchem.2024.108311_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/his.13230","article-title":"CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy","volume":"71","author":"Zwaenepoel","year":"2017","journal-title":"Histopathology"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124002998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927124002998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T22:52:54Z","timestamp":1740610374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927124002998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"alternative-id":["S1476927124002998"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108311","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring immune gene expression and potential regulatory mechanisms in anaplastic thyroid carcinoma using a combination of single-cell and bulk RNA sequencing data","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108311"}}